Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Physiologically Assessing Intermediate Stenosis: Could FFR Be Replaced?

Fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) are commonly used to assess physiological severity of angiographically intermediate stenosis. Both indexes quantify a pressure ratio as subrogate to measuring flow, which is much harder to do.

¿Podría el FFR ser reemplazado para la evaluación fisiológica de una lesión intermedia?

Discordance between FFR and iFR occurs in up to 20% of cases, which should not be a matter of concern, for in recent studies, such as the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularization) and the iFR-SWEDEHEART (Evaluation of iFR vs FFR in Stable Angina or Acute Coronary Syndrome), more than 4500 patients have shown that iFR guided revascularization resulted non inferior to FFR guided revascularization as regards major adverse events at one year.


Read also: Development of New Valves Lowers Need for Pacemaker”.


This study sought to determine the coronary flow characteristics of angiographically intermediate stenosis classified as discordant by FFR and iFR.

 

The present study, called IDEAL (Iberian–Dutch–English Collaborators), is the largest study to physiologically asses stenosis with a combination of both pressure based indexes (FFR and iFR) and Doppler flow velocity that has been published so far.

 

The study compared flow velocity and coronary flow reserve (CFR) at baseline and under hyperemia in 5 groups, one group with unobstructed vessels (201 vessels, n=153), and 4 with angiographically intermediate stenosis: FFR+/iFR+ (108 vessels, n=91), FFR-/iFR+ (28 vessels, n=24), FFR+/iFR- (22 vessels, n=22), and FFR-/iFR- (208 vessels, n=154).


Read also: Quality of Life Between Surgery and Angioplasty for the Treatment of Left Main Disease”.


Discordance between FFR and iFR was observed in 14% of patients (50 of 366). Baseline flow velocity was similar across all 5 groups, including, of course, the unobstructed vessel group.

 

In FFR+/iFR- discordants, hyperemic flow velocity and CFR resulted similar to the FFR-/iFR- groups and the unobstructed vessel group.


Read also:Coronary Artery Dissection in Women: Rare and Difficult to Manage”.


In FFR-/iFR+ discordants, hyperemic flow velocity and CFR resulted similar to the FFR+/iFR+ group.

 

Conclusion

FFR/iFR discordance was explained by differences in hyperemic coronary flow velocity. Coronary flow resulted similar in unobstructed vessels and in intermediate stenosis when FFR turned out positive and iFR turned out negative for ischemia (FFR+/iFR-).

 

Editorial Comment

Measuring the effect of stenosis on coronary flow is technically more demanding and takes longer than simply measuring pressure gradient, which is why flow velocity and CFR have been replaced by FFR in the daily practice. Not only is FFR simpler tan CFR, but it is also supported by a large body of evidence (DEFER, FAME, etc.).

 

The results of this study suggest that when there is FFR/iFR discordance, the most revealing index (the one closest to hyperemic flow velocity) is iFR. This poses serious questions to FFR use in the daily practice, since iFR, compared against FFR, is even simpler, faster, less expensive, and causes less discomfort for patients, with less adenosine-driven symptoms.

 

Original title: Fractional Flow Reserve/Instantaneous Wave-Free Ratio Discordance in Angiographically Intermediate Coronary Stenoses. An Analysis Using Doppler-Derived Coronary Flow Measurements.

Reference: Christopher M. Cook et al. J Am Coll Cardiol Intv 2017;10:2514–24.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

 

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...